A-423,579
From Infogalactic: the planetary knowledge core
Names | |
---|---|
IUPAC name
4-[4-[3-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]propoxy]-3,5-difluorophenyl]benzonitrile
|
|
Identifiers | |
461045-17-0 | |
ChEMBL | ChEMBL498228 |
ChemSpider | 9524593 (R) 13210784 |
Jmol 3D model | Interactive image Interactive image |
PubChem | 11349657 (R) 22994515 |
|
|
|
|
Properties | |
C22H25F2N3O | |
Molar mass | 385.4502 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
A-423,579 is one of a range of histamine antagonists developed by Abbott Laboratories which are selective for the H3 subtype, and have stimulant and anorectic effects in animal studies making them potentially useful treatments for obesity. A-423,579 has improved characteristics over earlier drugs in the series with both high efficacy and low toxicity in studies on mice, and is currently in clinical development.[1][2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Articles without KEGG source
- Articles without UNII source
- Pages using collapsible list with both background and text-align in titlestyle
- Chemical articles having calculated molecular weight overwritten
- Fluoroarenes
- H3 receptor antagonists
- Nitriles
- Phenol ethers
- Pyrrolidines
- Gastrointestinal system drug stubs